Orally administered dosage forms of GABA analog prodrugs having reduced toxicity

Details for Australian Patent Application No. 2002310409 (hide)

Owner Xenoport, Inc.

Inventors Gallop, Mark A.; Cundy, Kenneth C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002310409

PCT Number PCT/US02/18701

PCT Pub. Number WO2002/100392

Priority 60/298,514 14.06.01 US; 60/366,090 19.03.02 US; 60/297,521 11.06.01 US

Filing date 11 June 2002

Wipo publication date 23 December 2002

Acceptance publication date 2 August 2007

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/19 (2006.01)

A61K 31/197 (2006.01)

A61K 31/22 (2006.01)

A61K 31/27 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/06 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 39/02 (2006.01) General protective or antinoxious agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 271/22 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 323/58 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/298,514 14.06.01 US; 60/366,090 19.03.02 US; 60/297,521 11.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002310409

2 August 2007 Application Accepted

  Published as AU-B-2002310409

29 November 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 13 Nov 2007. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2003

13 December 2007 Standard Patent Sealed

17 April 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Nov 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002310410-RADAR DETECTION AND DYNAMIC FREQUENCY SELECTION FOR WIRELESS LOCAL AREA NETWORKS

2002310408-DUAL COMMUNICATION PORT SHARING APPARATUS